Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.630
+0.130 (5.20%)
At close: May 2, 2024, 4:00 PM
2.670
+0.040 (1.52%)
After-hours: May 2, 2024, 5:08 PM EDT

Vivos Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Vivos Therapeutics.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for VVOS.

Recommendation Trends

Rating Aug '22Sep '22Oct '22Nov '22Dec '22Jan '23
Strong Buy 222220
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222220

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Ascendiant Capital
Ascendiant Capital
Strong Buy
Initiates
$63
Strong Buy Initiates $63 +2,276.43% Jan 17, 2023
Roth Capital
Roth Capital
Strong Buy
Maintains
$275$250
Strong Buy Maintains $275$250 +9,405.70% Aug 13, 2021
Roth Capital
Roth Capital
Strong Buy
Maintains
$300$275
Strong Buy Maintains $300$275 +10,356.27% May 18, 2021
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$300
Strong Buy Initiates $300 +11,306.84% Jan 11, 2021
Roth Capital
Roth Capital
Strong Buy
Initiates
$300
Strong Buy Initiates $300 +11,306.84% Jan 5, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
17.59M
from 13.80M
Increased by 27.48%
Revenue Next Year
19.60M
from 17.59M
Increased by 11.40%
EPS This Year
-3.47
from -11.14
EPS Next Year
-1.53
from -3.47
Year 2019202020212022202320242025
Revenue
11.39M13.07M16.89M16.02M13.80M17.59M19.60M
Revenue Growth
200.43%14.68%29.23%-5.10%-13.87%27.48%11.40%
EPS
-23.75-35.00-24.00-25.90-11.14-3.47-1.53
EPS Growth
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 19.4M 20.2M
Avg 17.6M 19.6M
Low 15.7M 18.8M

Revenue Growth

Revenue Growth 20242025
High
40.8%
14.7%
Avg
27.5%
11.4%
Low
13.6%
7.0%

EPS Forecast

EPS 20242025
High -2.99 -1.58
Avg -3.47 -1.53
Low -3.87 -1.47

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.